15. CA125 as a Biomarker for Identifying Disease Severity and Right Ventricular Dysfunction in Obstructive Sleep Apnea
Open Access
- 1 January 2025
- journal article
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 29 (8) , 423-430
Abstract
Background: Obstructive sleep apnea (OSA) is associated with increased cardiovascular risk, particularly through right ventricular (RV) dysfunction. Cancer antigen 125 (CA125), a biomarker traditionally used in ovarian cancer, has shown potential as an indicator of RV dysfunction. This study aims to compare CA125 levels between OSA patients and controls and to evaluate its association with disease severity and subclinical RV dysfunction. Methods: This cross-sectional study included sixty OSA patients, divided into severe (apnea-hypopnea index [AHI] ≥ 30) and non-severe groups, and sixty age- and sex-matched controls. Cancer antigen 125 levels were assessed together with echocardiographic markers. Regression analysis identified predictors of severe OSA, and receiver operating characteristic (ROC) analysis assessed the diagnostic performance of CA125. Results: Cancer antigen 125 levels were significantly elevated in severe OSA patients compared to non-severe and control groups (median 34.3 vs. 12.9 vs. 10.3 U/mL, P < .001). Cancer antigen 125 correlated with RV fractional area change (RV-FAC) (r = −0.496, P < .001), tricuspid annular plane systolic excursion (TAPSE) (r = −0.285, P = .027), and AHI (r = 0.581, P < .001). Regression analysis identified CA125 (odds ratio [OR] = 1.259, 95% con-fidence interval [CI]: 1.102-1.438, P = .001) and TAPSE (OR= 0.425, 95% CI: 0.217-0.834, P = .013) as independent predictors of severe OSA. ROC analysis showed that CA125 could effectively predict RV dysfunction (area under the curve [AUC] = 0.857) and severe OSA (AUC = 0.804). Conclusion: Elevated CA125 levels are associated with increased disease severity and subclinical RV dysfunction in OSA, suggesting its potential as a biomarker for early cardiac involvement.Keywords
This publication has 35 references indexed in Scilit:
- Plasma B-type natriuretic peptide level is associated with left ventricular hypertrophy among obstructive sleep apnoea patientsJournal Of Hypertension, 2008
- Clinical and prognostic value of elevated CA125 levels in patients with congestive heart failure.2006
- Oxidative Stress in Obstructive Sleep ApneaChest, 2005
- Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational studyThe Lancet, 2005
- Serum levels of carbohydrate antigen 125 in patients with chronic heart failureJACC, 2003
- Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart FailureNew England Journal of Medicine, 2002
- Right ventricular dysfunction in patients with obstructive sleep apnoea syndromeEuropean Respiratory Journal, 1997
- CA-125 concentrations in malignant and nonmalignant diseaseClinical Chemistry, 1991
- Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour markerBritish Journal of Cancer, 1984
- Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation.Circulation, 1984